CD14 and hematoma: Pfkl is a subtype of Pfk, and in a previous transcriptomics study, the elevated level of Pfk gene expression in CD14+ monocytes/macrophages from hematoma tissue was reported to be significantly associated with good outcomes for ICH patients at the subacute stage [27].